Attached files
| file | filename |
|---|---|
| 8-K - NEWLINK 8-K FILED 20120328 - LUMOS PHARMA, INC. | nlnk-20120328x8k.htm |
| EX-1.HTM - SETTLEMENT AGREEMENT WITH THE IOWA ECONOMIC DEVELOPMENT AUTHORITY - LUMOS PHARMA, INC. | nlnk-20120328x8kxex01.htm |
Exhibit 10.2
2012 Target Bonus Awards
2012 Target Bonus | |||||||
Name and Title | Percentage of 2012 Base Salary | Total Target Bonus | |||||
Charles J. Link, Jr., M.D. Chairman of the Board and Chief Executive and Scientific Officer | 55% | $ | 283,250 | ||||
Nicholas N. Vahanian, M.D. President and Chief Medical Officer | 45% | $ | 180,000 | ||||
Gordon H. Link, Jr. Chief Financial Officer | 35% | $ | 97,405 | ||||
Kenneth Lynn Executive Vice President of Business Development | 30% | $ | 81,240 | ||||
W. Jay Ramsey, M.D., Ph.D. Quality Assurance Officer | 30% | $ | 81,870 | ||||